06.05.2014 Views

02 BOOK OF ABSTRACTS .indd

02 BOOK OF ABSTRACTS .indd

02 BOOK OF ABSTRACTS .indd

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Electrochemotherapy of cancer – therapeutic perspectives<br />

Gregor Ser{a for the ESOPE group<br />

Institute of Oncology, Zalo{ka 2, SI-1000 Ljubljana, Slovenia<br />

Electrochemotherapy consists of chemotherapy followed by local application of<br />

electric pulses to the tumour to increase drug delivery into cells. Drug uptake can<br />

be increased by electroporation for only those drugs whose transport through the<br />

plasma membrane is impeded. Among many drugs that have been tested so far,<br />

only bleomycin and cisplatin found their way from preclinical testing to clinical<br />

trials. In vitro studies demonstrated several fold increase of their cytotoxicity after<br />

electroporation of cells. In vivo, electroporation of tumours after local or systemic<br />

administration of either of the drugs, i.e. electrochemotherapy, proved to be an<br />

effective antitumour treatment<br />

Physico-chemical basis of this therapy allows prediction that electrochemotherapy<br />

has good antitumour effect on all tumour types, which was demonstrated in several<br />

clinical studies. The ESOPE clinical trial has demonstrated that an objective response<br />

rate of 85% (73.7% complete response rate) was achieved on the electrochemotherapy<br />

treated tumour nodules, regardless of tumour histology, and drug used or route of<br />

its administration.<br />

The clinical experience gained so far in the ESOPE project provided evidence that<br />

electrochemotherapy is successful treatment in various clinical indications:<br />

• Easy and effective treatment of single or multiple tumour nodules of any<br />

histology in the cutaneous and subcutaneous tissue.<br />

• Treatment that increases quality of life in patients with progressive disease.<br />

38l23<br />

• Treatment of choice for tumours refractory to conventional treatments.<br />

• Neoadjuvant treatment in form of cytoreductive therapy before conventional<br />

treatment.<br />

• Organ sparing and function saving treatment.<br />

• Treatment of hemorrhagic or painful nodules, since it reduces bleeding and in<br />

some cases pain level.<br />

All these indications provide electrochemotherapy broad spectrum of use, predominantly<br />

because electrochemotherapy is effective local therapy and additionally<br />

quick and easy to perform.<br />

• Ser{a G, Cema`ar M, Rudolf Z. Electrochemotherapy: advantages and drawbacks<br />

in treatment of cancer patients. Cancer Therapy 2003; 1: 133-42.<br />

• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment<br />

using enhanced delivery of bleomycin by electroporation. Cancer Treat<br />

Rev 2003; 29: 371-87.<br />

The ESOPE (QLK3-20<strong>02</strong>-<strong>02</strong>003) study was supported by EU commission project, and<br />

Research Agency of Slovenia.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!